Meetings and materials

The P&T Committee / DUR Board meet at least quarterly. All meetings are open to the public.

Meetings and materials: Pharmacy and Therapeutic (P&T) Committee/Drug Utilization Review (DUR) Board

Upcoming meetings

February 20, 2019

April 17, 2019

June 19, 2019

August 21, 2019

October 16, 2019

December 18, 2019

Materials

Drug class reports will be taken down 30 days after the meeting.

Date	General Documents	P&T Documents	P&T Motions	DUR Documents
December 19, 2018	Agenda (2018-12-19)	Asthma COPD CGRP Inhibitors Hormone therapy Newer diabetes Second Generation Antipsychotics		Drug class reviews
October 17, 2018	Agenda (2018-10-17) Transcript			Drug class reviews with motions Opioid policy
August 15, 2018	Agenda (2018-8-15) Transcript		Antiemetics Antiplatelets Hepatitis C Diabetes- long-acting insulins Multiple Sclerosis	Drug class reviews w/motions Apple Health Policies w/motions Apple Health preferred drugs
June 20, 2018	Agenda (2018-6-20) Transcript		ADHD Anticoagulants Antidepressants Overactive bladder TIMs	Drug class reviews and motions Antipsychotic dose limits and motion
April 18, 2018	Agenda (2018-4-18) Transcript		Biologic drugs- asthma/urticaria PCSK9 Inhibitors Quick relief asthma Statins	Apple Health policies & motions Drug class reviews & motions
March 21, 2018	Agenda (2018-3-21) Transcript			Drug class presentations with motions Apple Health polices with motions Apple Health preferred drugs
February 21, 2018	Agenda (2018-2-21) Transcript	P&T/DUR process overview		Drug class presentations and motions Apple Health policies

Meeting details

All P&T Committee/DUR Board meetings are open to the public.
Sign up at the meeting to testify on a drug class. Stakeholder sign-up sheets are located in the lobby.
Stakeholders will be allowed three minutes for comments.
If you would like to give testimony, but cannot attend a meeting, please email a two-page maximum letter to Leta Evaskus at least one week before the meeting. She will put your testimony in the P&T Committee binders. If your testimony is longer than two pages, contact Leta for an address to mail it to.
Committee discussion and motions follow stakeholder comments.
Meetings are sponsored by the Health Care Authority and meet requirements of the Americans with Disabilities Act. Please call our ADA Coordinator at 360-725-9976 to make a request for special accommodations. TRS users may call this number through the Washington Relay Service by dialing 711.

Medicaid supplemental rebates

Effective January 1, 2018 HCA joined The Optimal PDL Solution (TOP$) supplemental rebate pool administered by Provider Synergies, a subsidiary of Magellan Medicaid Administration, LLC.

Please refer to the TOP$ website for more information about contracting and submitting rebates.

For additional Medicaid questions, please send an email to Apple Health (Medicaid).